Bernales, Maylin B.
HRN: 21-65-97 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/02/2022
METRONIDAZOLE 500MG (TAB)
08/02/2022
08/09/2022
ORAL
500mg
TID
SP CS; PROM; TMSAF
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Intra-abdominalReproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes